Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kainate receptor subunit 5 (GluK5, previously known as KA2, gene name GRIK5) is a protein that forms part of the kainate receptor family, which belongs to the ionotropic glutamate receptor superfamily of ligand-gated ion channels[1][6]. These receptors mediate excitatory synaptic transmission in the central nervous system by responding to the neurotransmitter glutamate. GluK5 does not form functional homomeric receptors but combines with other subunits (notably GluK1-3) to create functional heteromeric channels, most commonly as heterodimers with GluK2[2][3][5]. Kainate receptors, including complexes involving GluK5, are important for modulating synaptic strength and plasticity, contribute to neuronal circuit function, and are implicated in several neurological and neurodegenerative diseases. Their precise subunit composition determines their biophysical and pharmacological properties. Pharmacological targeting of kainate receptors is an<seg_64>area of ongoing research; however, there are currently no GluK5-selective drugs in clinical use[1][5][6].
Agonists: Bind and activate the receptor, increasing cation flux, leading to neuronal depolarization Antagonists: Bind and block the receptor, inhibiting excitatory neurotransmission mediated by kainate receptors
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kainate receptor subunit 5 (GluK5).